Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID
OZM-077 (COZMOS)
Disease (Sub Disease)
Brain and Spinal Tumours (Ependymoma)
Diagnosis Stage
Relapse/ refractory
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
The Hospital for Sick Children
Trial Status
Closed to Recruitment
Trial Close Date
01/09/2021
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 year to 18 years
International registry ID's
NCT03206021
Back to Registry
Study Title Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID OZM-077 (COZMOS)
Disease (Sub Disease) Brain and Spinal Tumours (Ependymoma)
Diagnosis Stage Relapse/ refractory
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children
Links https://clinicaltrials.gov/ct2/show/NCT03206021
Trial Status Closed to Recruitment
Trial Open Date 01/09/2019
Trial Close Date 01/09/2021
Study Type Treatment
Phase Phase 1
Age Eligibility 1 year to 18 years
International registry ID's NCT03206021